FDA clears prasugrel, requires black-box warning

07/12/2009 | Bloomberg

The FDA approved prasugrel, an anti-clotting drug from Daiichi Sankyo and Eli Lilly. The product will be launched under the brand name Effient and carry a black-box warning about an increased risk of potentially fatal bleeding.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC